Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Neurotech International Limited (NTI.AX)

ASX - ASX Delayed Price. Currency in AUD
0.0860+0.0020 (+2.38%)
As of 10:17AM AEDT. Market open.
Advertisement

Neurotech International Limited

145 Stirling Highway
Suite 5 CPC
Nedlands, WA 6009
Australia
61 8 9389 3130
https://www.neurotechinternational.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Dr. Alexandra AndrewsChief Operating Officer331.03kN/AN/A
Prof. Allan Cripps A.O., AO, B.Sc., Ph.D.Chief Scientist & Innovation and Director40kN/AN/A
Dr. Emanuela RussoChief Scientific Officer & Member of Scientific Advisory BoardN/AN/AN/A
Mr. Gerald QuigleyDirector of PR & DirectorN/AN/AN/A
Dr. Thomas Duthy M.B.A., Ph.D.Exec. DirectorN/AN/AN/A
Mr. Peter James Lawrence Griffiths B.Sc.Chief Exec. Officer of AAT Research LtdN/AN/A1964
Ms. Erlyn Saromines Dawson A.C.I.S., ACIS, AGIA, B.Com., BCom., GradDipACGCompany Sec.N/AN/AN/A
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Neurotech International Limited, together with its subsidiaries, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. The company is focused on development and commercializing Mente platform, a platform technology to monitor and play role in home-based therapies. Its product includes Mente Autism for the diagnosis and treatment of autism. It also engages in executing of medical research projects; and developing of technological devices. The company was incorporated in 2016 and is based in Nedlands, Australia.

Corporate Governance

Neurotech International Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement